Cargando…

Comparative proteomics of wild-type and nef-deleted HIV-1 particles

Detalles Bibliográficos
Autores principales:	Brégnard, Christelle, Danos, Olivier, Basmacioqullari, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236917/ http://dx.doi.org/10.1186/1742-4690-8-S2-P3

Ejemplares similares

Understanding the nature of the Nef requirement for HIV-1 infectivity
por: Rosa, Annachiara, et al.
Publicado: (2013)

HIV-1 Nef targets calnexin: a novel mechanism behind Nef effects on host cell and viral proteins
por: Jennelle, Lucas, et al.
Publicado: (2013)

Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV
por: Meuwissen, PJ, et al.
Publicado: (2011)

Impairment of viral replication capacity by nef alleles from HIV elite controllers
por: Mwimanzi, Philip, et al.
Publicado: (2011)

HIV-1 Nef alters podosomes and promotes the mesenchymal migration in human macrophages
por: Vérollet, Christel, et al.
Publicado: (2013)

Functional characterization of HIV-1 Nef proteins with heterologous membrane targeting signals
por: Geist, Miriam M, et al.
Publicado: (2013)

Potential role of HIV-1 Nef and human M6B in HIV-associated neurological disorders
por: Moetter, Jessica, et al.
Publicado: (2010)

HIV-1 Nef compensates for disorganization of the Immunological Synapse by inducing TGN-associated Lck signaling
por: Pan, Xiaoyu, et al.
Publicado: (2011)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
por: Oniangue-Ndza, C, et al.
Publicado: (2009)

Critical role of calnexin in Nef-mediated inactivation of ABCA1
por: Jennelle, Lucas, et al.
Publicado: (2011)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012)

P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses
por: Montes, M, et al.
Publicado: (2009)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
por: Kyosiimire-Lugemwa, J, et al.
Publicado: (2009)

Naturally-arising amino acid polymorphisms of HIV-1 Nef that differentially modulate downregulation of HLA-A and HLA-B molecules
por: Mahiti, Macdonald, et al.
Publicado: (2013)

CD4.CD8 ratio decrease in AIDS, explained by a molecular mimicry between African HIV-1 Nef and Notch-1. Nef as a target for vaccine and NF-Kb inhibitors (salicylate, resveratrol,curcumin, epigallocatechine-3-gallate)
por: Tran, Guy MK, et al.
Publicado: (2012)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
por: Gabitzsch, ES, et al.
Publicado: (2009)

Chemotactic activity of HIV-1 Nef for human monocytes
por: Lehmann, MH, et al.
Publicado: (2006)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
por: Wild, J, et al.
Publicado: (2009)

P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV
por: Xie, J, et al.
Publicado: (2009)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

P18-04. MVA-nef vaccination induces specific T-cell responses exerting functions associated with non-progressive disease in HIV-1 infected individuals
por: Kutscher, S, et al.
Publicado: (2009)

The enhancement of HIV-1 infectivity by Nef depends on dynamin 2
por: Pizzato, Massimo, et al.
Publicado: (2006)

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo
por: Gorry, Paul R, et al.
Publicado: (2007)

Role of Rab proteins in the formation of HIV-1 particles
por: Caillet, Marina, et al.
Publicado: (2009)

The activity of Nef on HIV-1 infectivity
por: Basmaciogullari, Stéphane, et al.
Publicado: (2014)

P17-12. Immunogenicity comparison of dna vaccines encompassing HIV-1 tat, rev, integrase (C-half), vif and nef genes derived from different clades
por: Wan, Y, et al.
Publicado: (2009)

Changes of biological properties and pathogenesis of CAEV chimeras expressing Nef and Vpx/Vpr accessory proteins in infected goats
por: Jin, Yuhai, et al.
Publicado: (2009)

P03-04. Increased virulence of CAEV chimeras expressing Nef and Vpx/Vpr accessory proteins in infected goats
por: Jin, Y, et al.
Publicado: (2009)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
por: Fellay, J, et al.
Publicado: (2009)

Lipidomic dataset of plasma from patients infected with wild type and nef-deficient HIV-1 strain
por: Meikle, Peter, et al.
Publicado: (2015)

Maturation of protective immunity induced by SIVΔnef correlates with differential expression of transcription factors in SIV-specific CD8+ T cells
por: Billingsley, JM, et al.
Publicado: (2012)

Nef variants from non-pathogenic lentiviral strains inhibit iron uptake through an AP2-dependent inhibition of transferrin endocytosis
por: Koppensteiner, Herwig, et al.
Publicado: (2013)

TIP47 is required for the production of infectious HIV-1 particles from primary macrophages
por: Bauby, Hélène, et al.
Publicado: (2009)

Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors
por: Honarparvar, Bahareh, et al.
Publicado: (2013)

HIV-1 Nef: at the crossroads
por: Foster, John L, et al.
Publicado: (2008)

Array comparative genomic hybridization in confirmation of the deleted genes in a patient with subterminal deletion of the long arm of chromosome 10 associated with sagittal craniosynostosis and dysmorphic features
por: Faria, Ágatha Cristhina, et al.
Publicado: (2014)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

In silico analysis of drug resistance in wild type and mutant HIV-1 subtype d protease
por: Munusami, Punnagai, et al.
Publicado: (2014)

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient
por: Trabaud, MA, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sslimiqur46i4vu44lrjahalpf